What one share of Nextcure holds
We are a clinical-stage biopharmaceutical company that is focused on advancing innovative medicines that treat cancer patients that do not respond to, or that have disease progression on, current therapies, through the use of targeted therapies, including antibody-drug conjugates (“ADCs”).
Nextcure’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$9.97 |
|---|---|
| Cash and investments | $3.75 |
| Book value | $2.99 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2018 | — | −$199.72 | $26.83 | $43.18 | — | −$409.75 |
| 2019 | $4.85 | −$25.79 | $2.58 | −$29.81 | $0.00 | $140.29 |
| 2020 | $9.75 | −$15.95 | $3.11 | −$22.70 | $0.00 | $127.85 |
| 2021 | — | −$30.15 | $1.03 | −$25.92 | $0.00 | $101.18 |
| 2022 | — | −$32.32 | $0.92 | −$24.22 | $0.00 | $72.38 |
| 2023 | — | −$27.04 | $0.35 | −$23.19 | $0.00 | $49.21 |
| 2024 | — | −$23.88 | $0.20 | −$17.71 | $0.00 | $28.05 |
| 2025 | — | −$19.65 | — | — | $0.00 | $9.97 |
Common questions about Nextcure
How much does one share of Nextcure earn?
Over the last 12 months, Nextcure lost $9.97 for each share.
Does Nextcure pay a dividend?
Nextcure didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Nextcure’s book value per share?
Nextcure’s book value is $2.99 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Nextcure have?
Each share of Nextcure has $3.75 of cash and investments, as of June 30, 2026.
Has Nextcure bought back shares?
Nextcure’s share count rose about 2390% from 2018 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.